A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease. Academic Article

Overview

abstract

OBJECTIVE: To investigate the safety and efficacy of oral bovine type I collagen (CI) treatment in patients who have had diffuse cutaneous systemic sclerosis (dcSSc; scleroderma) for

authors

Postlethwaite, Arnold E

Clements, Philip

Chatterjee, Soumya

Fessler, Barri J

Merkel, Peter A

Molitor, Jerry A

Moreland, Larry

Rothfield, Naomi

Simms, Robert W

Spiera, Robert F
Steen, Virginia
Warrington, Kenneth
White, Barbara
Wigley, Frederick
Furst, Daniel E

publication date

June 1, 2008

published in

Arthritis and rheumatism Journal

Research

keywords

Collagen Type I
Immunosuppressive Agents
Scleroderma, Diffuse

Identity

PubMed Central ID

PMC4511098

Scopus Document Identifier

45349109299

Digital Object Identifier (DOI)

10.1002/art.23501

PubMed ID

18512816

Additional Document Info

has global citation frequency

89

volume

58

issue

6